Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by (Responsible Party):
RFS Pharma, LLC
ClinicalTrials.gov Identifier:
NCT01738555
First received: November 28, 2012
Last updated: March 27, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)